The current study showed that the frequency of any grade AEs in patients with epilepsy was more than 2 times higher for those receiving CBD than for the controls, with a notably increased risk of ALT or AST elevation, decreased appetite, diarrhea, and somnolence in those receiving CBD. The gene discussed is GPT; the disease is epilepsy.